Utility Model Application News Today

CAGAYAN DE ORO CITY - With the newly acquired License to Operate (LTO) from the Food and Drug Administration (FDA), SG Business Ventures Inc., a woman-led

As of April 1, 2022, “Multi-multi claims“ are restricted by a Ministerial Order amendment referring to “claims that selectively cite two or more other claims and claims that selectively cite the citations of two or more other claims.“ Multi-multi claims are no longer allowed in patent and utility model applications filed in Japan. The purpose is to pursue the goal of international harmonisation and reduce the burden of examination processing and monitoring by third parties.